Filing Details

Accession Number:
0001567619-20-017592
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-10-05 17:33:16
Reporting Period:
2020-10-01
Accepted Time:
2020-10-05 17:33:16
Original Submission Date:
2020-10-05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533743 Processa Pharmaceuticals Inc. PCSA Pharmaceutical Preparations (2834) 451539785
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1681718 H James Stanker C/o Processa Pharmaceuticals, Inc.
7300 Coca Cola Drive, Suite 106
Hanover MD 21076
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-01 6,000 $4.00 47,248 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This amended Form 4 is being filed to correct the purchase price for the reported transaction.